US › Healthcare

Viemed Healthcare Inc (VMD)

US · Healthcare · Medical Devices

$9.84-15.87%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$75.4M
Revenue YoY
+27.5%
Net profit
$2.6M
Profit YoY
-1.6%
EPS
$0.06
EPS estimate
$0.09
Net margin
3.4%

EPS came in at 0.06 against a street estimate of 0.09 — a miss of 33.3%.

Key statistics

Market cap
$446.6M
P/E
32.4
Forward P/E
27.0
P/B
3.17
Book value
$3.72
EPS (TTM)
$0.36
52-week high
$12.61
52-week low
$5.93
50-day MA
$10.97
200-day MA
$8.76
Beta
1.10

Analyst view

Analysts rate Viemed Healthcare Inc a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $11.00.

Shareholding

Insiders
13.67%
Institutions
66.44%

Largest institutional holders

FundStake
BlackRock Inc12.06%
Forager Capital Management, LLC7.37%
Vanguard Group Inc4.65%
The Goldman Sachs Group Inc3.71%
Vanguard Capital Management, LLC3.40%
Ameriprise Financial Inc2.34%
Nantahala Capital Management, LLC2.31%
Geode Capital Management, LLC2.03%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Viemed Healthcare Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.